Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 45 Records) |
| Query Trace: Cholangiocarcinoma and IDH1[original query] |
|---|
| Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker. European journal of cancer (Oxford, England : 1990) 2019 Aug 120 31-39. Chae Heejung, Kim Deokhoon, Yoo Changhoon, Kim Kyu-Pyo, Jeong Jae Ho, Chang Heung-Moon, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Hwang Shin, Kim Ki-Hun, Song Gi-Won, Ahn Chul Soo, Lee Jae Hoon, Hwang Dae Wook, Kim Song Cheol, Jang Se Jin, Hong Seung-Mo, Kim Tae Won, Ryoo Baek-Ye |
| Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2019 Nov . Kusano Hironori, Naito Yoshiki, Mihara Yutaro, Kondo Reiichiro, Ogasawara Sachiko, Akiba Jun, Nakashima Osamu, Yano Hirohi |
| Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features. Scientific reports 2020 9 10 (1): 15820. Lee Kyoungbun, Song Young Seok, Shin Yoonju, Wen Xianyu, Kim Younghoon, Cho Nam-Yun, Bae Jeong Mo, Kang Gyeong Ho |
| Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients. JCO precision oncology 2020 4 . Cao Jingyu, Hu Jing, Liu Siqin, Meric-Bernstam Funda, Abdel-Wahab Reham, Xu Junjie, Li Qiang, Yan Maolin, Feng Yujie, Lin Jianzhen, Zhao Songhui, Wang Jian, Kwong Lawrence N, Hu Jinwei, Carapeto Fernando, Borad Mitesh J, Wang Kai, Javle Milind, Zhao Hait |
| Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population. Pathology, research and practice 2020 Sep 216 (9): 153116. Pu Xiaohong, Zhu Liya, Li Feng, Zheng Jinyu, Wu Hongyan, Fu Yao, Chen Jun, Qi Lia |
| Characteristics of genomic alterations in Chinese cholangiocarcinoma patients. Japanese journal of clinical oncology 2020 Jun . Jiang Guoping, Zhang Wu, Wang Ting, Ding Songming, Shi Xiaoliang, Zhang Shuirong, Shi Weiwei, Liu Angen, Zheng Shus |
| Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
| Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns. The oncologist 2021 Jun . Israel Mason A, Danziger Natalie, McGregor Kimberly A, Murugesan Karthikeyan, Gjoerup Ole, Sokol Ethan S, Tukachinsky Hanna, Kurzrock Razelle, Kato Shumei, Sicklick Jason K, Nimeiri Halla S, Oxnard Geoffrey R, Ross Jeffrey |
| Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 5 27 (14): 4101-4108. Jolissaint Joshua S, Soares Kevin C, Seier Kenneth P, Kundra Ritika, Gönen Mithat, Shin Paul J, Boerner Thomas, Sigel Carlie, Madupuri Ramyasree, Vakiani Efsevia, Cercek Andrea, Harding James J, Kemeny Nancy E, Connell Louise C, Balachandran Vinod P, D'Angelica Michael I, Drebin Jeffrey A, Kingham T Peter, Wei Alice C, Jarnagin William |
| Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma. Hepatology (Baltimore, Md.) 2021 3 74 (3): 1429-1444. Boerner Thomas, Drill Esther, Pak Linda M, Nguyen Bastien, Sigel Carlie S, Doussot Alexandre, Shin Paul, Goldman Debra A, Gonen Mithat, Allen Peter J, Balachandran Vinod P, Cercek Andrea, Harding James, Solit David B, Schultz Nikolaus, Kundra Ritika, Walch Henry, D'Angelica Michael I, DeMatteo Ronald P, Drebin Jeffrey, Kemeny Nancy E, Kingham T Peter, Simpson Amber L, Hechtman Jaclyn F, Vakiani Efsevia, Lowery Maeve A, Ijzermans J N M, Buettner S, Koerkamp B Groot, Doukas M, Chandwani Rohit, Jarnagin William |
| Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. BMC cancer 2021 Feb 21 (1): 152. Xu Shifeng, Guo Yuan, Zeng Yanwu, Song Zhijian, Zhu Xiaodan, Fan Ning, Zhang Zhilei, Ren Guibing, Zang Yunjin, Rao W |
| Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. Journal of personalized medicine 2021 12 11 (12): . De Brian, Abu-Gheida Ibrahim, Patel Aashini, Ng Sylvia S W, Zaid Mohamed, Thunshelle Connor P, Elganainy Dalia, Corrigan Kelsey L, Rooney Michael K, Javle Milind, Raghav Kanwal, Lee Sunyoung S, Vauthey Jean-Nicolas, Tzeng Ching-Wei D, Tran Cao Hop S, Ludmir Ethan B, Minsky Bruce D, Smith Grace L, Holliday Emma B, Taniguchi Cullen M, Koong Albert C, Das Prajnan, Koay Eugene |
| Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma. Virchows Archiv : an international journal of pathology 2021 12 480 (5): 1077-1085. Yamashita Hironori, Tourna Aikaterini, Akita Masayuki, Itoh Tomoo, Chokshi Shilpa, Ajiki Tetsuo, Fukumoto Takumi, Youngson Neil A, Zen Y |
| Ivosidenib Boosts OS in Cholangiocarcinoma. Cancer discovery 2021 10 11 (12): 2953-2954. Authors are not available |
| Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
| Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis. Targeted oncology 2022 Sep 17 (5): 591-596. Rimini Margherita, Burgio Valentina, Antonuzzo Lorenzo, Rimassa Lorenza, Oneda Ester, Lavacchi Daniele, Personeni Nicola, Ratti Francesca, Pedica Federica, Della Corte Angelo, Persano Mara, De Cobelli Francesco, Aldrighetti Luca, Scartozzi Mario, Cascinu Stefano, Casadei-Gardini Andr |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
| Ferroptosis in Intrahepatic Cholangiocarcinoma: IDH1 Single Nucleotide Polymorphism Is Associated With Its Activation and Better Prognosis. Frontiers in medicine 2022 7 9 886229. Sarcognato Samantha, Sacchi Diana, Fabris Luca, Zanus Giacomo, Gringeri Enrico, Niero Monia, Gallina Giovanna, Guido Mar |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 2022 Jun 6 e2100274. Uson Junior Pedro Luiz Serrano, Majeed Umair, Yin Jun, Botrus Gehan, Sonbol Mohamad Bassam, Ahn Daniel H, Starr Jason S, Jones Jeremy C, Babiker Hani, Inabinett Samantha R, Wylie Natasha, Boyle Ashton W R, Bekaii-Saab Tanios S, Gores Gregory J, Smoot Rory, Barrett Michael, Nagalo Bolni, Meurice Nathalie, Elliott Natalie, Petit Joachim, Zhou Yumei, Arora Mansi, Dumbauld Chelsae, Barro Oumar, Baker Alexander, Bogenberger James, Buetow Kenneth, Mansfield Aaron, Mody Kabir, Borad Mitesh |
| FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (13): 2733-2737. Casak Sandra J, Pradhan Shan, Fashoyin-Aje Lola A, Ren Yi, Shen Yuan-Li, Xu Yuan, Chow Edwin Chiu Yuen, Xiong Ye, Zirklelbach Jeanne Fourie, Liu Jiang, Charlab Rosane, Pierce William F, Fesenko Nataliya, Beaver Julia A, Pazdur Richard, Kluetz Paul G, Lemery Steven |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters. European journal of cancer (Oxford, England : 1990) 2022 Sep 175 299-310. Rimini Margherita, Loi Eleonora, Fabregat-Franco Carles, Burgio Valentina, Lonardi Sara, Niger Monica, Scartozzi Mario, Raposelli Ilario G, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Zavattari Patrizia, Casadei-Gardini Andr |
| Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
| Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study. International journal of cancer 2022 Jun . Niger Monica, Nichetti Federico, Casadei-Gardini Andrea, Rizzato Mario Domenico, Pircher Chiara, Bini Marta, Franza Andrea, Rimini Margherita, Burgio Valentina, Sposetti Caterina, Fornaro Lorenzo, Rapposelli Ilario Giovanni, D'Amico Francesco Enrico, Aprile Giuseppe, Vivaldi Caterina, Frassineti Giovanni Luca, Milione Massimo, Leoncini Giuseppe, Cappetta Alessandro, Vasile Enrico, Fassan Matteo, Morano Federica, Perrone Federica, Tamborini Elena, Pruneri Giancarlo, Lonardi Sara, Mazzaferro Vincenzo, Pietrantonio Filippo, Di Bartolomeo Maria, de Braud Filip |
| Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
| Platinum Sensitivity in IDH1/2 mutated Intrahepatic Cholangiocarcinoma: Not all "BRCAness" is Created Equal. Cancer investigation 2023 7 1-11. Deborah Blythe Doroshow, Wei Wei, Meenakshi Mehrotra, Daniella Sia, Joseph Paul Eder, Ranjit Bindra, Jane Houldsworth, Patricia LoRusso, Zenta Walth |
| Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
| Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study. Journal of cancer research and clinical oncology 2023 5 . Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, Chris Verslype, Eric Van Cutsem, Tania Roskams, Sabine Tejpar, Isabelle Vanden Bempt, Jeroen Dekerv |
| Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients. Targeted oncology 2023 1 18 (1): 139-145. Rimini Margherita, Fabregat-Franco Carles, Persano Mara, Burgio Valentina, Bergamo Francesca, Niger Monica, Scartozzi Mario, Rapposelli Ilario Giovanni, Aprile Giuseppe, Ratti Francesca, Pedica Federica, Verdaguer Helena, Rizzato Mario, Nichetti Federico, Lai Eleonora, Cappetta Alessandro, Macarulla Teresa, Fassan Matteo, De Braud Filippo, Pretta Andrea, Simionato Francesca, De Cobelli Francesco, Aldrighetti Luca, Fornaro Lorenzo, Cascinu Stefano, Casadei-Gardini Andr |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: